Pharmaceutical Composition, Methods For Treating And Uses Thereof

Abstract

The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing metabolic disorders, such as type 1 or type 2 diabetes mellitus or pre-diabetes, in patients with renal impairment or chronic kidney disease (CKD).


Claims
Owners (US)

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Apr 24, 2018
  • Application: Oct 21, 2015
    US US 201514918727 A
  • Priority: Oct 21, 2015
    US US 201514918727 A
  • Priority: Apr 3, 2014
    US US 201414244208 A
  • Priority: Nov 26, 2013
    US US 201361908991 P
  • Priority: Apr 5, 2013
    US US 201361808804 P

Download Citation


Sign in to the Lens

Feedback